# Psychedelics Stock, Up 190% This Year, Flies High Again

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-15 02:29 UTC · Category: Business · Sources: 12 · Current Velocity: 11.26

## Intelligence Brief
"Psychedelics Stock, Up 190% This Year, Flies High Again" developed substantial multi-source reporting across the Business sector, tracked across 12 distinct newsrooms by Newsylist.


Key reporting was led by Pharmaceutical Technology, TipRanks, Yahoo Finance and Dealroom. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Psychedelics Stock, Up 190% This Year, Flies High Again?
Coverage spiked when 12 independent newsrooms published 13 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Key People, Organizations & Locations
Stock, Again, Year, High, Psychedelics, Flies

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Pharmaceutical Technology | Definium tees up regulatory submission for psychedelic on Phase III hat trick | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxPOFNJd0UyS3VqUGJtMl9PUUl5ZWV6enJFUHFfdFZHRC0zM3d2TWJnWVhFckZFb3hsYjNlYk9WMnAzR1VWbE5xSnlheEo5Q0tyMmRoTEFzQ041S1YtNjEyOGwwRERabUFHUFAtejBRWmRyNEpGV1dZZUhXMFNTVzNJbVJYV0luT0oxZnVJRGF6V2F2Z3d0S3FRUTNEcU0?oc=5) |
| TipRanks | Definium Therapeutics price target raised to $75 from $70 at Oppenheimer | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxPMjMyM1A0OUkzQ1dQZW9fRWwwbDNyUW9oUlZyY3lTLUtPb3BZVXhYenhuUW56VXA4cmlodWVtdTFpZ0l5TzNTQVhIUDM0Q3B4bmJTN0p1S1czc1ZLcm1Jb25hV2V3ZnltMXRoa2VQeFNjakZva2NQVThFM0QtR3RCeXBTNXBYZnJNbkpnaU01azI0Z0lnQklLYTNhZlQ5NllwcWNfLWtZaG1fUW1rZVh5am9vdXJrMGZJdkJVQg?oc=5) |
| Yahoo Finance | Definium Reports Second Phase III Success in Anxiety Disorder Program | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxNRy1PcEVjUVo4ckhRWGZyOFhObEo1SGVsbFI5Q1JyREhFdHk2SUxnSFpNV3ptUllNY09nRGp1dDlOU0pMZ2c0Zk5EenljdnlZLUZwaXc2NGVxeXpEYlUzZGFFcWpBMWxteHVZSmtHbGRiQ2I4UGlWSzVQLTdUQVRMRHhqcDFTR2xlNjQ5UUhRbU0wdEJhTVNOb3Z3?oc=5) |
| Dealroom | Definium Therapeutics notches third straight Phase 3 win as DT120 psychedelic hits goals in generalised anxiety disorder | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMi6gFBVV95cUxOV0dCOS1tWHNic0lFUjFzRVNDZGh4dWJ2Ny1NM2FDOXBSQ3pVYjUyUFJzWE9aS0NPZmh1Snh5NmVrdTZsYnM4Y0hldVc2cGU0eUtIU2stSy1SdkRLdXIyMjJxcjBSTlIzbzBTVEI2U3duRS1RMHNmRzVoTkI4Tks1YnczOENHM1MtcXU1MkJGUF9nOEZLeWt3NnJpWlk5WURyUnRtcVM1ekRWVGpGUDNhNVRCMUJpMU5heU9zODhiYUNxTVlDWTBENjc3dXVKQzRPTm1qMV96Z2hFOThCRm5HdmZnT25qSXZrdWc?oc=5) |
| GuruFocus | DFTX Maintained by Baird -- Price Target Raised to $79.00 | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxNaHdNaHJZYjFQTS1EbDY4VWpfTU1zZl9DWVZLQlVROHRLa1JxTjAzMGpuSlZEbWlDZVJBamJqVHJFR2o5ZjliV3V3Q1JpejVRa3JDUHNRdDA2Q3pOZzNTR0xYanNuN2oySTQwQ2s1Ung1RXpkc29nbWl0V0laVEh4VFFJUG84M0d4aHAtaGp3LVcwanRhLXc?oc=5) |
| businesswire.com | Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMilAJBVV95cUxOZWdiQkVYUzJzak5DNVpaR3RXSklEVW5tY01GR2FuSVNzQUdDLUd3U0ZiR3l0VW1ULU1yWmd5eDZEZEk1eTNLclA2NEIxdWx2RDF6N3U4RWZna2ZkRmRDU2czdFJHc3RpNlpxWU02TlhvYkkxWnd5aEdhTUlIUi14QVl1eHdXMno5SVNELVJMVmhJUU05eWVzWW40b05BTVVLeGZ5cnN4YkIyQU1hV0NXZUMycVZkeVYyRWxSaVZUdDE4cVU5NFVLQ2dGbGFaR0FqSGRkYktJMzctdUJqOGxpTVlmcHhTZlZRM0Jqd0h4MHlGcVFZc1JPQ3JoTzRtVlo1WVBHUzhPVXdOMmR3enBGOVJSUzQ?oc=5) |
| BioSpace | Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’ | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMixAFBVV95cUxPM3JmTVhyVjdIejBONE1lRHZwNHA5OHhaM0M3U21VdzlFYUs5V3VDUnN1YmZ0WFVzb0xWQTZrZUt1T0taZEFudldkbE8tclVYVkVUcFdfSEgzRWhMeFFhOThiYjREQ2hZV0Fud3JhSmNUc0JxSWVxc28tS1ZCcGpRaDRsNzgwbjV4cEdNd1RsQ0tRdzNFUGEwS0JaV2dHcWNSdEdLS0Q2ajZDbzNGanJQRm9RTldCYTQteGw0bW1WWldkcDcw?oc=5) |
| STAT | Definium’s LSD therapy eased anxiety in second large trial | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxNa205MHAyM04wZFlUS1dOYUcxSGdDM2FFRVcxTVdybmNUQjdHd2RmOEt2dTF1RXpud3E0RHl0cnhzVEY0cS13U2JQN1lJakY1RFhhU1RKVWFoTU1KRUREU2xGR2tJR3lDbENaME55RF82dnl4RlB1WE1Ga0dlZXl3bk9uaDBYcWFTbjVsazZPZ3BFWmVSYi1sRzhBa0Y?oc=5) |
| Yahoo Finance | Definium Therapeutics Announces Positive Topline Results from Phase 3 Panorama Study of DT120 ODT in Generalized Anxiety Disorder | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxPQlUwUk91QlU1MUMtdmk0WVBVNFdlNlpOMHFTc0JNTlpBZ0NnY1pyTlpKNGdxbllHM2o3ejB6VlFJYmVHRTNzUVE3dVA5Q3VjcENUaDlDM2t3LVNnRGNRdktpZzhtVkRfbTZtZlBsYXhWMFhLZEpHNjhXajZjZVplYWJLcllhUlJxRkNzS1Y2d1ZmWEJ5N2d0cjN3M2pSSFBYMXUtbDZCV2dzMkVnSHc?oc=5) |
| FirstWord Pharma | Definium's psychedelic notches another Phase III win in anxiety | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWQ2xPM0RCc2pEaHNpRklmZnBia1JCNWZTNi1CYlBnRHUyb0dxVFg5cC1IdFZsRmFBODB1cTM3WExjekY0MjRWbnVfYWdld1dONmFJ?oc=5) |
| Fierce Biotech | Definium LSD drug goes 3 for 3 with another pivotal anxiety trial win | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxOZ3hnZEpYUkhFRHM2Nzd6dmdFUEs5cjlldGF2VjFXeE9mVEx6dU5nZ2hLSVhWU3d2ZklPc25IcFBpelFUVnphVTlOZktPNXFWemVlMzJTQUtrSWlNQUwwVm9idExTaFVKTElkNTUyZVQzazgxQ2NXX21SVTd0UUtjUm9pTFItdTJSY2JoLWJYWFhXLWoxWFpzWUpZeG5lTEk?oc=5) |
| Reuters | Definium's LSD-based anxiety, depression drug scores another trial win | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMi3wFBVV95cUxNWHNUYU9wTUxWWTdITnNZc0l3dnJsdlZCZ29uOE5RVWc3QWpmUmZ2RW83UHpfNUdxby13T0FPSHNqQkhud0xmMm4tWnZpaTNacHZHMzdFUFZXSDczM0dUNTRJdE1xc2RZQ19vTTA3anJmUl8xSXhoWk5PazJvSXFKdmdFUWlvNHJQdnBDd0VYLTVHUzJpOGpfTTczNzJOakdhd2QxNl9WMWwyVmpuYjI4ZGp4NHpvd1RiSTdsbWlETlBlYnJLZWZwYXMycWU5UHVzWHA2ME1sS0g3Zy1JRFdB?oc=5) |
| Investor's Business Daily | Psychedelics Stock, Up 190% This Year, Flies High Again | 2026-09-14 20:10 | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxNdlZoaWJZbGpuek1tVkxVbll0LVNIazZzbFZ0eEdkNFA2RXllSnBaQkdZajdBV29mMGdHRFJjd2pDX2cyS0h1Nm5BRl9rbWZBNk9rUFM5TFRsYUJrZDUtTll5ejVQcUxUanNZczN0ZmpORWxxaXl4NEFUTmZWdkk0SWk5VXVwX2NSWUxMZzRUWDFiWEt6SXFYNjk2bE0yMXFjbDlmcmxuWXQwYnM?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-15/psychedelics-stock-up-190-this-year-flies-high-again*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*